Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teun Bousema

Showing results (321-330 of 340) with videos related to

Pageof 34
Sort By:
The Journal of Infection|April 30, 2026
Parasite and gametocyte dynamics and infectivity to mosquitoes during recurrent Plasmodium vivax infections; a longitudinal study from EthiopiaFitsum G Tadesse, Wakweya Chali, Legesse Alamerie Ejigu, et al.
The New England Journal of Medicine|November 20, 2024
Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria ParasiteOlivia A C Lamers, Blandine M D Franke-Fayard, Jan Pieter R Koopman, et al.
Nature Medicine|October 26, 2023
Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in AfricaTadele Emiru, Dejene Getachew, Maxwell Murphy, et al.
Immunity|February 15, 2023
Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoesAmanda Fabra-García, Sophia Hailemariam, Roos M de Jong, et al.
Science Translational Medicine|June 7, 2019
Naturally acquired immunity against immature <i>Plasmodium falciparum</i> gametocytesKathleen W Dantzler, Siyuan Ma, Priscilla Ngotho, et al.
The Lancet. Infectious Diseases|February 7, 2025
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trialA Fabrice Somé, Anthony Somé, Emmanuel Sougué, et al.
Malaria Journal|December 10, 2014
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaNicholas J White, Elizabeth A Ashley, Judith Recht, et al.
Emerging Infectious Diseases|January 26, 2021
Anopheles stephensi Mosquitoes as Vectors of Plasmodium vivax and falciparum, Horn of Africa, 2019Fitsum G Tadesse, Temesgen Ashine, Hiwot Teka, et al.
Nature Communications|September 7, 2017
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmissionDavid A Baker, Lindsay B Stewart, Jonathan M Large, et al.
Nature Communications|April 13, 2018
Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.
Pageof 34

Showing results (321-330 of 340) with videos related to

Sort By:
Pageof 34
The Journal of Infection|April 30, 2026
Parasite and gametocyte dynamics and infectivity to mosquitoes during recurrent Plasmodium vivax infections; a longitudinal study from EthiopiaFitsum G Tadesse, Wakweya Chali, Legesse Alamerie Ejigu, et al.
The New England Journal of Medicine|November 20, 2024
Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria ParasiteOlivia A C Lamers, Blandine M D Franke-Fayard, Jan Pieter R Koopman, et al.
Nature Medicine|October 26, 2023
Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in AfricaTadele Emiru, Dejene Getachew, Maxwell Murphy, et al.
Immunity|February 15, 2023
Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoesAmanda Fabra-García, Sophia Hailemariam, Roos M de Jong, et al.
Science Translational Medicine|June 7, 2019
Naturally acquired immunity against immature <i>Plasmodium falciparum</i> gametocytesKathleen W Dantzler, Siyuan Ma, Priscilla Ngotho, et al.
The Lancet. Infectious Diseases|February 7, 2025
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trialA Fabrice Somé, Anthony Somé, Emmanuel Sougué, et al.
Malaria Journal|December 10, 2014
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaNicholas J White, Elizabeth A Ashley, Judith Recht, et al.
Emerging Infectious Diseases|January 26, 2021
Anopheles stephensi Mosquitoes as Vectors of Plasmodium vivax and falciparum, Horn of Africa, 2019Fitsum G Tadesse, Temesgen Ashine, Hiwot Teka, et al.
Nature Communications|September 7, 2017
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmissionDavid A Baker, Lindsay B Stewart, Jonathan M Large, et al.
Nature Communications|April 13, 2018
Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.
Pageof 34